GLP1R and obesity due to melanocortin 4 receptor deficiency: Notably, there was no interaction effect between the GLP1R GRS and either diabetes (P = .98) or overweight or obesity (P = .47), indicating that the association of higher GLP1R expression with lower risk of kidney disease progression was consistent across subgroups.